Connexin 43 is a potential prognostic biomarker for ewing sarcoma/primitive neuroectodermal tumor.
- Additional Document Info
- View All
Connexins (Cxs) are building unit proteins of gap junctions (GJs) that are prognostic markers in carcinomas. To investigate the role of Cx in Ewing sarcoma (EWS)/primitive neuroectodermal tumor (PNET), we examined the expression of Cx43 and Cx26 in 36 EWS/PNETs and found (1) cytoplasmic Cx43 reactivity in 28/36 (78%) cases. (2) Cx43 score was significantly correlated with overall survival (P = .025). The average scores for patients alive and dead at 3 years are 46.08 and 96.98 (P = .004) at 5 years are 46.06 and 96.42 (P = .002). (3) Metastasis had a significant effect on the overall survival (P = .003). (4) Cytoplasmic Cx26 reactivity was detected in 2 of 36 (6%) patients who died with metastasis. Our results suggest a possible oncogenic and prognostic role for Cx43 and Cx26 in EWS/PNET. The lack of membranous immunoreactivity suggests that the effect of Cx in EWS/PNET is via a GJ function-independent mechanism.
author list (cited authors)
Bui, M. M., Han, G., Acs, G., Reed, D., Gonzalez, R. J., Pasha, T. L., & Zhang, P. J.
complete list of authors
Bui, Marilyn M||Han, Gang||Acs, Geza||Reed, Damon||Gonzalez, Ricardo J||Pasha, TL||Zhang, Paul J